Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy male volunteers; aged 18 to 45 years;~* Body mass index (BMI) between 18.0 and 30.0 kg/m2 inclusive, weight ≥ 50 kg;~* Non- smokers or ex-smokers;~* Able to give informed consent.~Exclusion Criteria:~* Subjects with evidence or history of clinically significant disease;~* Positive results to HIV Ag/Ab Combo, Hepatitis B surface Antigen (HBsAG (B) (hepatitis B)) or Hepatitis C Virus (HCV (C)) tests;~* Subjects who have received any investigational drug in the previous 28 days;~* Subjects participated in a study with PI3k inhibitors at least once in past year;~* Subjects who have received drugs metabolised by CYP3A4 enzyme in the previous 28 days.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- RP6530 in fast condition (Type: EXPERIMENTAL): A single dose of RP6530 following fast condition
- RP6530 in fed condition (Type: EXPERIMENTAL): A single dose of RP6530 following fed condition

Based on this trial design, predict the completion outcome and termination type (if applicable).